Learn More
Medchemexpress LLC MK-2206 dihydrochloride | 1032350-13-2 | MFCD14584463 | 99.9% | 480.4 g/mol | C25H23Cl2N5O | 25 MG

Supplier: Medchemexpress LLC HY1035825MG
MK-2206 dihydrochloride is an orally active, brain-penetrant allosteric inhibitor of Akt used in preclinical research to modulate PI3K/Akt signaling. It selectively inhibits Akt1, Akt2, and Akt3 with low-nanomolar potency and has been reported to induce autophagy in cellular models.
- Allosteric Akt inhibitor with low-nanomolar IC50s for Akt1, Akt2, and Akt3.
- Induces autophagy in cell-based assays.
- Orally active and brain penetrant, suitable for in vivo studies.
- Supplied as a solid powder, soluble in DMSO for solution preparation.
- High purity (>99%), supporting reproducible experimental results.
- Suitable for in vitro and preclinical in vivo research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.